Meridian Clinical Trials Paul-TanPiengco

Nick Damiano has spent his career as a healthcare entrepreneur, innovator, and leader. He is currently Co-Founder & CEO of Zenflow, which is developing a novel office-based therapy to relieve symptoms of benign prostatic hyperplasia (BPH). Zenflow has raised over $40 million in funding from top VCs and has conducted successful clinical trials in four countries. Prior to Zenflow, Nick co-founded Avail MedSystems (f.k.a. Nurep), a venture-backed telemedicine company. He also spent a year as a Stanford Biodesign Innovation fellow and held engineering roles for various medtech startups.

Speaker Details